...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New trial

"I was wrong to say free, unqualified." 

"Happy to entertain opposing points of view."

No, you hit perfect it on your first sentence then kinda went onto oppose yourself.

Share
New Message
Please login to post a reply